Low Growth Hormone Individuals: Certain individuals produce below-normal growth hormone secretion, and these peptides can replace more normal secretions

1371-C NON-ALCOHOL FATTY LIVER DISEASE IN A PROSPECTIVE NATIONAL COHORT OF HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ANTIVIRAL THERAPY Wen Xie, Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China, Lihua Cao, The Third Hospital of Qinhuangdao City, Hebei, China, Shuangsuo Dang, The Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China, Liying Zhu, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China, Dongliang Yang, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Hubei, China, Yueyong Zhu, The First Affiliated Hospital of Fujian Medical University, Fujian, China, Xiaoguang Dou, Shengjing Hospital Affiliated with China Medical University, Liaoning, China, Zhiliang Gao, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong, China, Binbin Chen, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Xinxin Zhang, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Yuming Wang, Chongqing Public Health Medical Center, Chongqing, China, Yan Liu, Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China, Ting Zhang, Center of Liver Diseases Division, Beijing Ditan Hospital, Capital Medical University, Beijing, China and Calvin Pan Pan, New York University Langone Medical Center, Flushing, NY Background: The non-alcohol fatty liver disease (NAFLD) had been reported in 27% of Chinese adults with chronic hepatitis B (CHB)

Any suspected side effects from medicines should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
Join here.
What This May Mean for Patients None of this regulatory context is unique to altRx, and altRx itself is one of many telehealth platforms operating in this space